Gold Silver Reports (GSR) – Biocon Rises After Bengaluru Facility Clears Regulatory Inspection – Shares of the drugmaker rose as much as 2.3 percent to Rs 644.35. – The company said that it received an Establishment Inspection Report (EIR) from the U.S. drug regulator for its manufacturing facility in Bengaluru, according to its stock exchange notification.
